605 filings
Page 6 of 31
8-K
lnimlggh9
26 Aug 20
JanOne Inc. (JAN) CEO Tony Isaac on Drug Candidate JAN101 - Telebriefing and Corporate Update Call Transcript
6:01am
8-K
wh33m u4sznysfztkc
19 Aug 20
Regulation FD Disclosure
10:00am
8-K
3l4atv c1oo
18 Aug 20
Regulation FD Disclosure
10:01am
8-K
x1o833hh3l3wct38
12 Aug 20
Regulation FD Disclosure
6:03am
8-K
vktgj dtw
6 Aug 20
JanOne Engages CATO SMS, a World-Leading CRO, to Assist in the Development of JAN101 to Treat COVID-19 Vascular Complications
2:45pm
8-K
bj94zqp3
30 Jul 20
JanOne bolsters its scientific advisory board with two leaders in the medical field for vascular regeneration and interventional pain
9:42am
8-K
5a1opl5s8gz5toaosqzk
21 Jul 20
JanOne Receives FDA Authorization for Transfer of Investigational New Drug (IND) Application for its Sodium Nitrite Tablets
9:25am
8-K
b7sz0t4l9d
8 Jul 20
Other Events
9:31am
8-K
ozl9j23kj1
30 Jun 20
One of the nation’s most renowned pain experts, Dr. Edgar Ross, joins JanOne’s Scientific Advisory Board
9:31am
8-K
wdwu4gx68919b2 jz9fi
25 Jun 20
Other Events
10:00am
8-K
js0u5
18 Jun 20
JanOne Launches Strategic Alternatives Process for Legacy Businesses
9:38am
SC 13G
onsp9g 9mjnxf
18 May 20
JanOne / Energy Efficiency Investments ownership change
5:12pm
8-K
9rz8j7 2n
4 May 20
Entry into a Material Definitive Agreement
4:46pm
8-K/A
l9n0sfbdn8bnft2h
23 Apr 20
Departure of Directors or Certain Officers
6:05am
8-K
qlz9b
22 Apr 20
Departure of Directors or Certain Officers
4:30pm
NT 10-K
qgx 8wkdmh6
30 Mar 20
Notice of late annual filing
12:00am
8-K
469s0 w8ya
7 Feb 20
JanOne strikes agreement with CoreRx, a leading cGMP contract manufacturer, for Phase 2b clinical formulation and development
12:00am